Aristotle Atlantic Partners, LLC Dexcom Inc Transaction History

Aristotle Atlantic Partners, LLC

$3.19 Billion
Q3 2024

A detailed history of Aristotle Atlantic Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Aristotle Atlantic Partners, LLC holds 199,445 shares of DXCM stock, worth $15.1 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

199,445

Previous 199,254 0.1%

Holding current value

$15.1 Million

Previous $22.6 Million 40.83%

% of portfolio

0.42%

Previous 0.73%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $12,224 - $22,167	191 Added 0.1%	199,445 $13.4 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $133,254 - $169,663	-1,208 Reduced 0.6%	199,254 $22.6 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $307,480 - $377,149	-2,692 Reduced 1.33%	200,462 $27.8 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $175,363 - $288,423	2,323 Added 1.16%	203,154 $25.2 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $124,184 - $199,032	-1,443 Reduced 0.71%	200,831 $18.7 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $4.11 Million - $4.79 Million	36,544 Added 22.05%	202,274 $26 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $5,200 - $6,146	50 Added 0.03%	165,730 $19.3 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $1,444 - $2,085	-17 Reduced 0.01%	165,680 $18.8 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $97,498 - $120,267	1,277 Added 0.78%	165,697 $13.3 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $8.43 Million - $16.5 Million	124,044 Added 307.22%	164,420 $12.3 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $15,052 - $20,832	160 Added 0.4%	40,376 $20.7 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $25,194 - $31,587	194 Added 0.48%	40,216 $21.6 Million
Q3 2021 Nov 15, 2021	BUY	$106.71 - $143.18 $34,040 - $45,674	319 Added 0.8%	40,022 $21.9 Million
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $3,158 - $4,209	39 Added 0.1%	39,703 $17 Million
Q1 2021 May 17, 2021	BUY	$84.79 - $104.74 $3,222 - $3,980	38 Added 0.1%	39,664 $14.3 Million
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $72,072 - $96,558	924 Added 2.39%	39,626 $14.7 Million
Q3 2020 Nov 16, 2020	BUY	$95.51 - $112.95 $3,438 - $4,066	36 Added 0.09%	38,702 $16 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $634,572 - $1.07 Million	10,124 Added 35.47%	38,666 $15.7 Million
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $1.36 Million - $2.16 Million	28,542 New	28,542 $7.69 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Atlantic Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Atlantic Partners, LLC with notifications on news.

Account

Aristotle Atlantic Partners, LLC Dexcom Inc Transaction History